← Browse by Condition
Medical Condition

uterine fibroids

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05862272 Phase 3
Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Enrollment
1,000 pts
Location
United States
Sponsor
Sumitomo Pharma Switzerland Gm...
View Trial →